INTRA CELLULAR THERAPIES INC's ticker is and the CUSIP is 46116X901. A total of 6 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,567,000 | – | 100,000 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 175,000 | $2,271,000 | 0.21% |
| Worth Venture Partners, LLC | 51,200 | $99,000 | 0.06% |
| GROUP ONE TRADING, L.P. | 48,900 | $635,000 | 0.01% |
| SIMPLEX TRADING, LLC | 1,380 | $1,791,000 | 0.01% |
| JPMORGAN CHASE & CO | 154,800 | $1,968,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |